Skip to main content
HR 5150 115th Congress House

Protecting Medicare from Excessive Price Increases Act of 2018

Official title: To amend title XVIII of the Social Security Act to require drug manufacturers to pay a Medicare part B rebate for certain drugs if the price of such drugs increases faster than inflation.

Introduced: March 1, 2018 See on congress.gov
Health Business recordsCivil actions and liabilityCongressional oversightGovernment studies and investigations
More subjectsShow fewer subjects
Health care costs and insuranceInflation and pricesManufacturingMedicarePrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 9, 2018
Referred to the Subcommittee on Health.
Mar 2, 2018
Referred to the Subcommittee on Health.
Mar 1, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 1, 2018
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 9, 2018

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Protecting Medicare from Excessive Price Increases Act of 2018

This bill requires a drug manufacturer to pay a Medicare rebate on a single-source drug or biological in accordance with the extent to which the manufacturer's average sales price for the drug or biological increases faster than inflation.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 1
All 1 Democratic 1
D
Chu, Judy
California · Apr 18, 2018
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5150: Protecting Medicare from Excessive Price Increases Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-5150/
MLA
"H.R. 5150: Protecting Medicare from Excessive Price Increases Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-5150/.
Bluebook (legal)
H.R. 5150, 115th Cong. (2026), https://openamerica.io/bill/115-HR-5150/.
Markdown link
[H.R. 5150: Protecting Medicare from Excessive Price Increases Act of 2018](https://openamerica.io/bill/115-HR-5150/)
Report a problem